Market Tracker

01/17 5:19pm ET

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of 8:00pm ET
 +1.18 / +1.36%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Unbelievable ETFs & Stocks On Sale
12:21pm / - Paid Partner Content
Covenant Asset Management, LLC Buys SPDR Series Trust S&P Biotech, Cheniere Energy In...
Jan 12 / GuruFocus News - Paid Partner Content
Reversal Offers Chance in 2 Small Biotechs
11:12am / - Paid Partner Content
3 Sector ETFs for 2018
Jan 08 / - Paid Partner Content


1 month+6.08% 3 years+9.95%
3 months-0.06% 5 years+22.73%
1 year+33.74% Since inception+15.29%
Data through 01/17/2018

Quote Details

Previous close$86.84
Open day’s range87.05 – 88.33
Net asset value (NAV)86.79 (01/16/2018)
Daily volume6,473,695
Average volume (3 months)3,898,875
Data as of 8:00pm ET, 01/17/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+22.73%+17.28%
Expense Gross exp ratio0.35%1.32%
Risk 5 year sharpe ratio0.851.11
Net assets$4.2B$3.0B
Average market cap$3.6B$9.3B
Average P/E--21.8
Dividend / Share--0.33%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IMMU Immunomedics Inc1.71%
ARRY Array Biopharma Inc1.71%
EXEL Exelixis Inc1.68%
CLVS Clovis Oncology Inc1.64%
BMRN Biomarin Pharmaceutical Inc1.63%
UTHR United Therapeutics Corp1.63%
FOLD Amicus Therapeutics Inc1.63%
MDXG MiMedx Group Inc1.61%
AVXS AveXis Inc1.61%
NBIX Neurocrine Biosciences Inc1.58%